TrialJournal of the American Academy of Child and Adolescent Psychiatry2021

Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up.

Neurofeedback Collaborative GroupPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.